Therapy News and Research

RSS

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced the publication of a scientific paper by Dr. John R. Crew of Seton Medical Center, Daly City, California, describing the first use of adjunctive NeutroPhase irrigation therapy in conjunction with Negative Pressure Wound Therapy to successfully manage the severely-infected wound in the arm of a patient with life-threatening 'flesh-eating' disease.

20 Nov 2013

Metal coil therapy may provide same benefits as major surgery for COPD

Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.

20 Nov 2013

Linde Healthcare introduces intelligent digital oxygen cylinders with integrated pressure regulators

The new generation of oxygen cylinders, with an integrated pressure regulator that calculates and shows remaining time to the exact minute. LIV IQ is also equipped with various visible and audible alerts which enhance patient safety in mobile oxygen therapy. All together, these features free up time for healthcare professionals to concentrate on the patient and enable a cost-effective use of cylinder content.

20 Nov 2013

State highlights: Calif. fines three insurers for denying therapy; Colo.'s Denver Health to shed jobs; Ambulance Co. agrees to pay feds $3M over fraud allegations

California officials said three of the state's largest health insurers illegally denied speech and occupational therapy to patients, and regulators fined one of the companies, Health Net Inc., $300,000 for repeated violations. The state Department of Managed Health Care said Monday that it ordered Health Net, Anthem Blue Cross and Blue Shield of California to stop denying medically necessary therapy in cases of developmental disabilities, autism and other medical conditions.

20 Nov 2013

Special issue on Helicobacter pylori provides new insights into diagnosis, prevention and treatment

A special issue on Helicobacter pylori has been published by Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Gut Microbes have been authored by world-class investigators and provide new insights into the pathophysiology, diagnosis, prevention, and treatment of this microbe.

20 Nov 2013

Mount Sinai researchers win Best Manuscript Award for research on repair, reversal of heart attack damage

The Editors of the American Heart Association's (AHA) journal Circulation Research have awarded Icahn School of Medicine at Mount Sinai researchers a "Best Manuscript Award" for their investigations on repair and reversal of heart attack damage.

20 Nov 2013

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Nonarteritic anterior ischemic optic neuropathy is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.

20 Nov 2013

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has determined that a gene-based method for selecting patients' doses of the popular heart medication warfarin is no better than standardized dosing methods. The study was presented today at the 2013 Scientific Sessions of the American Heart Association and published simultaneously in the New England Journal of Medicine.

20 Nov 2013

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute.

20 Nov 2013

HIPAA-secure social network launched solely for Autism community

Autism Spectrum Disorder is the fastest growing developmental disability in the United States, affecting 1 in 88 children, according to the CDC. As more families struggle to find answers and make sense of a diagnosis, National Autism Network announces the launch of an innovative, HIPAA-secure social network designed specifically and solely for the Autism community. This fully integrated social network offers features not currently found on any social network and was created to fill a void in the community.

20 Nov 2013

First patients enrolled in EF-21 Study of NovoTTF Therapy for brain metastases from NSCLC cancer

Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF Therapy for patients with brain metastases from non-small cell lung carcinoma cancer. NovoTTF Therapy is an anti-mitotic treatment delivered continuously throughout the day by the NovoTTF-100A System.

20 Nov 2013

Serametrix launches new MDSC-based blood test for cancer patients

Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.

20 Nov 2013

Loyola University initiates clinical trial of vaccine that trains immune system to fight melanoma

Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.

20 Nov 2013

Researchers report long-term benefits of gene therapy in advanced heart failure patients

Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the American Heart Association Scientific Sessions 2013.

20 Nov 2013

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.

20 Nov 2013

Study: Most popular apps for iPhones lack some basic strategies to help smokers quit

An estimated 11 million smokers in the United States own a smartphone and increasingly they're turning to apps in an attempt to quit. But many of the most popular anti-smoking apps for iPhones or Androids lack some basic strategies that are known to help smokers quit, according to a new study in the American Journal of Preventive Medicine.

20 Nov 2013

UC San Diego study suggests racial inequality leads to higher mortality in cancer patients

Researchers at the University of California, San Diego School of Medicine say metastatic colorectal cancer patients of African-American descent are less likely to be seen by cancer specialists or receive cancer treatments. This difference in treatment explains a large part of the 15 percent higher mortality experienced by African-American patients than non-Hispanic white patients.

20 Nov 2013

Bipolar disorder treatment nonadherence ‘needs more attention’

More than half of patients with bipolar disorder fail to take their medication as prescribed, a study of Finnish inpatients and outpatients has found.

19 Nov 2013

Brain signals in fibromyalgia patients: an interview with Dr. Marco Loggia from Massachusetts General Hospital and Harvard Medical School in Boston

Fibromyalgia patients suffer from a variety of symptoms, including widespread body pain and myofascial tenderness. They are ‘hyperalgesic’, which means that if you give them a stimulus that in healthy subjects is just mildly painful (or even completely innocuous), they may perceive it as excruciatingly painful.

19 Nov 2013

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network, led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device heart pump may also benefit from a single dose of millions of powerful cells injected directly into their heart during surgery.

19 Nov 2013

Therapy News and Research

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

Metal coil therapy may provide same benefits as major surgery for COPD

Linde Healthcare introduces intelligent digital oxygen cylinders with integrated pressure regulators

State highlights: Calif. fines three insurers for denying therapy; Colo.'s Denver Health to shed jobs; Ambulance Co. agrees to pay feds $3M over fraud allegations

Special issue on Helicobacter pylori provides new insights into diagnosis, prevention and treatment

Mount Sinai researchers win Best Manuscript Award for research on repair, reversal of heart attack damage

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

HIPAA-secure social network launched solely for Autism community

First patients enrolled in EF-21 Study of NovoTTF Therapy for brain metastases from NSCLC cancer

Serametrix launches new MDSC-based blood test for cancer patients

Loyola University initiates clinical trial of vaccine that trains immune system to fight melanoma

Researchers report long-term benefits of gene therapy in advanced heart failure patients

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

Study: Most popular apps for iPhones lack some basic strategies to help smokers quit

UC San Diego study suggests racial inequality leads to higher mortality in cancer patients

Bipolar disorder treatment nonadherence ‘needs more attention’

Brain signals in fibromyalgia patients: an interview with Dr. Marco Loggia from Massachusetts General Hospital and Harvard Medical School in Boston

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News